BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.83 Cr | ₹-1.41 Cr | ₹-1.20 Cr | ₹-0.68 Cr | ₹-0.65 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BETA DRUGS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1.83 Cr |
| Mar2024 | ₹-1.41 Cr |
| Mar2023 | ₹-1.20 Cr |
| Mar2022 | ₹-0.68 Cr |
| Mar2021 | ₹-0.65 Cr |
How is Deferred Tax Assets / Liabilities of BETA DRUGS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.83 Cr | Negative | |
| Mar2024 | ₹-1.41 Cr | Negative | |
| Mar2023 | ₹-1.20 Cr | Negative | |
| Mar2022 | ₹-0.68 Cr | Negative | |
| Mar2021 | ₹-0.65 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,509.4 Cr | -4.5% | 19.6% | 30.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -4.5% |
19.6% |
30.7% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses